SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report)’s share price shot up 8.1% during trading on Monday . The stock traded as high as $14.99 and last traded at $14.83. 32,225 shares were traded during mid-day trading, a decline of 87% from the average session volume of 246,155 shares. The stock had previously closed at $13.72.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on SIBN shares. Truist Financial raised their target price on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Needham & Company LLC reissued a “buy” rating and set a $19.00 price objective on shares of SI-BONE in a research note on Monday. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, SI-BONE presently has a consensus rating of “Buy” and an average target price of $23.00.
Get Our Latest Analysis on SIBN
SI-BONE Stock Down 3.3 %
Insider Activity
In related news, CFO Anshul Maheshwari sold 2,439 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $12.68, for a total transaction of $30,926.52. Following the completion of the sale, the chief financial officer now directly owns 194,623 shares of the company’s stock, valued at approximately $2,467,819.64. This trade represents a 1.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Anthony J. Recupero sold 3,937 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $12.60, for a total transaction of $49,606.20. Following the completion of the transaction, the insider now owns 228,554 shares in the company, valued at $2,879,780.40. This represents a 1.69 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,348 shares of company stock valued at $356,349 in the last three months. Corporate insiders own 3.90% of the company’s stock.
Institutional Trading of SI-BONE
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Harbor Capital Advisors Inc. boosted its holdings in SI-BONE by 35.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 841,045 shares of the company’s stock valued at $11,791,000 after purchasing an additional 220,555 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of SI-BONE by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 177,793 shares of the company’s stock valued at $2,486,000 after buying an additional 22,732 shares during the last quarter. Franklin Resources Inc. grew its position in shares of SI-BONE by 9.4% during the third quarter. Franklin Resources Inc. now owns 20,220 shares of the company’s stock worth $265,000 after buying an additional 1,745 shares in the last quarter. Barclays PLC increased its stake in shares of SI-BONE by 190.8% in the third quarter. Barclays PLC now owns 96,623 shares of the company’s stock worth $1,350,000 after buying an additional 63,402 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in SI-BONE by 3.4% in the third quarter. Geode Capital Management LLC now owns 924,044 shares of the company’s stock valued at $12,921,000 after acquiring an additional 30,005 shares in the last quarter. 98.11% of the stock is owned by hedge funds and other institutional investors.
SI-BONE Company Profile
SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.
See Also
- Five stocks we like better than SI-BONE
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Can Integrated Healthcare Stocks Succeed in Public Markets?
- Roth IRA Calculator: Calculate Your Potential Returns
- What Lucid’s Partnership With SoundHound Means for LCID Stock
Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.